Malcolm Taub is listed as a director on 11 SEC Form D filings by 2 issuers between Jul 2012 and Jul 2023: BRAINSTORM CELL THERAPEUTICS INC. (New York, NY — biotechnology — 2012–2019; $10.5M reported sold to 11 investors) and Cruiser Capital, Ltd. (Camana Bay, Grand Cayman, Cayman Islands (as filed: E9) — pooled investment fund — 2019–2023; $4.03M reported sold to 10 investors).
What this means 2 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $14.5M sold in total.
Listed alongside Chaim Lebovits (6 shared filings), Chen Schor (6 shared filings), Keith M. Rosenbloom (5 shared filings), Alon Pinkas (4 shared filings), Irit Arbel (4 shared filings) and 13 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Malcolm. Each name links to their own page.
1 of the issuers belongs to the sponsor group Cruiser (4 issuers, $77.5M reported sold, 2011–2023).
What this means A sponsor group is one team that sets up a new company for each deal. Cruiser has 4 companies on file and $77.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 11 public filings for Malcolm Taub and found 11 differences, 1 worth asking the sponsor about: Form D filed 2,283 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.